Exercise fatigue
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 18-45 years, regardless of gender; 2. BMI between 18.5 and 23.9 kg/m^2; 3. Engage in aerobic exercise for at least 3 days per week, with a minimum duration of 30 minutes per day (accumulating a weekly total of 600 MET-min/w to 3,000 MET-min/w), maintained for at least 3 months; 4. The individual's physical activity status is good, with no contraindications to exercise. (1) Absolute contraindications to exercise include: 1) Acute myocardial infarction within the past 2 days; 2) Persistent unstable angina pectoris; 3) Uncontrolled arrhythmias accompanied by hemodynamic changes; 4) Active endocarditis; 5) Symptomatic severe aortic stenosis; 6) Decompensated heart failure; 7) Acute pulmonary embolism, pulmonary infarction, or deep vein thrombosis; 8) Acute myocarditis or pericarditis; 9) Acute aortic dissection; 10) Physical disability that poses safety concerns or prevents test completion. (2) Relative contraindications to exercise include: 1) Confirmed obstructive coronary artery stenosis; 2) Moderate to severe aortic stenosis with atypical symptoms; 3) Tachycardia with an uncontrolled ventricular tachycardia; 4) Late acquired or complete heart block; 5) Recent stroke or transient ischemic attack; 6) Mental impairment that hinders cooperation; 7) Severe hypertension, defined as systolic blood pressure >200 mmHg or diastolic blood pressure >110 mmHg; 8) Correctable medical conditions such as severe anemia, significant electrolyte imbalance, or hyperthyroidism; 5. Signing an informed consent form.
Exclusion criteria
Exclusion criteria: 1. Smokers (Have smoked continuously or cumulatively >=6months) or regular alcohol consumers (alcohol consume > 25g/day for male and > 15g/day for female); 2. Within the past three months (prior to the first administration of the study product), participated in or currently participating in, or planning to participate in other clinical trials; 3. Used antibiotics within the past three months or during the intervention period; 4. Currently undergoing or about to undergo drug treatment or consuming dietary supplements (including phytochemicals); 5. Regular consumption of coffee or strong tea, with a frequency of more than 3 times per week and each intake containing more than 200 mg of caffeine; 6. Allergic to chicory or milk; 7. Impaired glucose tolerance, high blood sugar, or diabetes; 8. Individuals with organic disorders in the heart, liver, kidneys, blood system, or other chronic diseases; 9. Seeking any other methods for exercise fatigue recovery, such as acupuncture, massage, hot water baths, sauna, electrical stimulation, foam rollers, or changes in dietary habits before the completion of the study; 10. Unable to undergo physical function tests or answer questionnaire questions accurately; 11. Unable to comply with the trial procedures.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Time to exhaustion; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood lactate;Heart rate;Maximal oxygen uptake;Bloos glucose;Blood pressure;pH;Bicarbonate; | — |
Countries
China
Contacts
Sun Yat-sen University